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Transgenic Overexpression of 14-3-3 Zeta Protects
Hippocampus against Endoplasmic Reticulum Stress and
Status Epilepticus In Vivo
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David C. Henshall1*
1Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland, 2Department of Biochemistry, University of Mississippi Medical
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Abstract
14-3-3 proteins are ubiquitous molecular chaperones that are abundantly expressed in the brain where they regulate cell
functions including metabolism, the cell cycle and apoptosis. Brain levels of several 14-3-3 isoforms are altered in diseases of
the nervous system, including epilepsy. The 14-3-3 zeta (f) isoform has been linked to endoplasmic reticulum (ER) function
in neurons, with reduced levels provoking ER stress and increasing vulnerability to excitotoxic injury. Here we report that
transgenic overexpression of 14-3-3f in mice results in selective changes to the unfolded protein response pathway in the
hippocampus, including down-regulation of glucose-regulated proteins 78 and 94, activating transcription factors 4 and 6,
and Xbp1 splicing. No differences were found between wild-type mice and transgenic mice for levels of other 14-3-3
isoforms or various other 14-3-3 binding proteins. 14-3-3f overexpressing mice were potently protected against cell death
caused by intracerebroventricular injection of the ER stressor tunicamycin. 14-3-3f overexpressing mice were also potently
protected against neuronal death caused by prolonged seizures. These studies demonstrate that increased 14-3-3f levels
protect against ER stress and seizure-damage despite down-regulation of the unfolded protein response. Delivery of 14-3-3f
may protect against pathologic changes resulting from prolonged or repeated seizures or where injuries provoke ER stress.
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Introduction
14-3-3 proteins are a ubiquitous family of molecular chaperones
of which seven isoforms are known in mammals (b, e, c, g, f, h,
and s). 14-3-3 proteins regulate cell proliferation, differentiation,
metabolism and apoptosis [1]. 14-3-3 proteins are present within
synapses and are important for the function and localization of ion
channels [2]. 14-3-3 proteins can also function as sweepers of
misfolded proteins [3] and promote protein trafficking from the
endoplasmic reticulum (ER) [4]. Genetic deletion studies have
demonstrated non-redundant roles for certain isoforms in brain
development and function [5,6] while aberrant expression of 14-3-
3 proteins has been implicated in several diseases of the nervous
system [2].
Prolonged seizures (status epilepticus) or repeated seizures over
time (pharmacoresistant epilepsy) can damage the brain [7].
Excitotoxicity is a key mechanism, whereby prolonged over-
activation of glutamate receptors results in loss of intracellular
calcium homeostasis, oxidative stress, damage to intracellular
organelles, and necrosis [8,9]. Seizures also trigger release of
apoptogenic proteins from mitochondria and downstream caspase-
dependent and -independent neuronal death [10,11]. 14-3-3
proteins may be important upstream regulators of apoptosis-
associated signalling after seizures. 14-3-3 proteins dissociate from
pro-apoptotic proteins such as Bad and apoptosis signal-regulating
kinase 1 (ASK-1) after experimental status epilepticus, promoting
neuronal death [12,13,14]. While some 14-3-3 isoforms are down-
regulated after seizures [12,15], levels of the zeta (f) isoform are
increased [15,16,17]. This may be neuroprotective since depleting
14-3-3f levels in vitro exacerbates kainic acid excitotoxicity [17].
Reduced 14-3-3f expression was reported during epilepsy
development [18] and 14-3-3f is also involved in the function of
tuberin, mutations in which result in neurological phenotypes
including seizures [19].
Although 14-3-3 proteins are mainly cytosolic they are also
found in the ER-containing microsomal fraction [15,20]. ER
functions include regulating protein folding and trafficking and
intracellular calcium storage [21]. Cell stress can result in the
three-branched unfolded protein response (UPR) [22]. Ire1, an
endoribonuclease, cleaves the X-box binding protein 1 (Xbp1)
transcript resulting in upregulation of molecular chaperones such
as Bip (glucose-regulated protein 78/GRP78); cleavage of
activating transcription factor 6 (ATF6) leads to increased ATF4
levels and modulators of ER stress; activation of protein kinase
RNA (PKR)-like ER kinase (PERK) which phosphorylates
eukaryotic initiation factor 2a (eIF2a) leading to a shut-down in
protein translation. If ER stress persists, the ATF6 and PERK
branches trigger apoptosis through up-regulation of CHOP and
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activation of caspases [23]. ER stress may be an important
pathophysiological component in experimental and human
temporal lobe epilepsy (TLE) [24,25,26,27,28]. Moreover, inhibi-
tion of ER stress can protect against seizure-induced neuronal
death [25,29].
Whether 14-3-3f can protect the hippocampus against either
ER stress or seizure-induced neuronal death in vivo is unknown. To
test this idea we studied ER stress and the response to seizures in
transgenic mice over-expressing 14-3-3f.
Methods
14-3-3f Mice
Generation of 14-3-3f-overexpressing mice (hereafter referred
to as 14-3-3ftg) has previously been reported [30]. The SJL mice
express myc-tagged mouse 14-3-3f under the control of the
ubiquitous elongation factor 1a (EF1a) promoter. Transgene
expression was confirmed by Western blot analysis of the myc tag
in protein lysates from tail snips, as described [30]. Heterozygous
males and wild-type females were bred together to obtain
heterozygous 14-3-3ftg and wild-type littermate controls. Mouse
body and brain weight was recorded in 6 week old animals.
Seizure Model
All mouse experiments were performed in accordance with
the European Communities Council Directive (86/609/EEC)
and were reviewed and approved by the Research Ethics
Committee of The Royal College of Surgeons in Ireland
(REC#205) under license from the Department of Health,
Dublin, Ireland. Food and water was available to mice ad
libitum. Induction of status epilepticus in SJL wild-type and 14-3-
3ftg mice was performed as previously described [31]. Briefly,
mice were anaesthetised with isoflurane and placed in a mouse
adapted stereotaxic frame. After making a mid-line scalp
incision, three partial craniectomies were performed for
placement of skull electrodes. A fourth full craniectomy was
drilled for the placement of a guide cannula (Coordinates from
Bregma: anterior-posterior (AP) =20.3 mm and laterally
(L) =20.3 mm) [32]. The cannula and electrodes were fixed
in place and mice allowed to recover before being placed in a
Perspex container. The EEG was recorded using a Grass Comet
Digital EEG. After baseline EEG was established, an injection
cannula was lowered through the guide cannula 3.75 mm below
the brain surface for the injection of kainic acid (Sigma-Aldrich)
into the basolateral amygdaloid nucleus. After 40 min all mice
received an i.p. injection of lorazepam (6 mg/kg) to curtail
seizures and reduce mortality and morbidity. For i.c.v injections,
mice were fitted with a cannula as described [33] and received
1 ml injection of 50 mM tunicamycin (Sigma-Aldrich).
EEG was analysed using Grass software with additional
frequency and amplitude analyses of EEG data performed by
uploading the data to an automated EEG analysis programme
(LabChart pro v7 software, ADInstruments Ltd) [33]. Seizures
were defined as the duration of high amplitude (.26baseline) high
frequency (.5 Hz) discharges and calculated between the time of
KA injection and lorazepam [33].
Hippocampal Primary Neuron Culture
Hippocampal primary neurons were cultured as previously
described [34]. Briefly, neurons from wt or 14-3-3ftg E18 embryos
were cultured for 6 days and then exposed to 3 mM KA for 24 h
followed by assessment of cell death by propidium iodide staining.
Cell death was expressed as a % of total cells.
Western Blotting
Hippocampus was microdissected to obtain CA1, CA3 and
dentate gyrus enriched portions, as described [33,34]. For
analysis of basal levels in naı¨ve mice, subfields were pooled from
both hemispheres. Samples were homogenised in lysis buffer
containing 0.01 M Tris-HCl and 1 mM EDTA. Proteins were
separated by SDS-polyacrylamide gel electrophoresis, transferred
to nitrocellulose membranes and then incubated with antibodies
as follows; Tubulin (Sc-8035, 1:10,000), 14-3-3 f, b, e, g, c, h
(Sc-1019, -1657, -135816, -17286, -731, -59414, 1:5,000),
GluR6/7 (Sc-28797, 1:2,000), Calnexin (Sc-11397, 1:1,000)
(All Santa Cruz Biotechnology), Bax (2772, 1:500), Bim (2819,
1:100), Lamin A/C (2032, 1:500), p-eIF2a (9721, 1:1,000),
Caspase-12 (2202, 1:1,000) (all Cell Signaling Technology),
NeuN (MAB377, 1:400), GFAP (AB1540, 1:1,000), KA2 (06-
315, 1:2,000), KDEL (420400, 1:500) (all Millipore), Bad
(ab32445, 1:500), Iba1 (ab5076, 1:1,000), Porin (ab15895,
1:4,000), ATF4 (ab23760, 1:500) (all Abcam), ATG5 (NB110-
53818, 1:1,000) (Novus Biologicals). Membranes were next
incubated with HRP –conjugated secondary antibodies (1:2,000
Millipore) and bands visualised using Imobilon western HRP
substrate (Millipore) using a FujiFilm LAS-4000 system under
chemiluminescence.
RNA Isolation, cDNA Synthesis and Real-time PCR
Total RNA was extracted from brain samples using Trizol as
previously described [35]. First strand cDNA synthesis was
performed using 1 mg of total RNA and SuperScript II reverse
transcriptase (Invitrogen) primed with 50 pmol of random
hexamers. Quantitative real-time PCR was performed using the
LightCycler (Roche Diagnostics, Basal, Switzerland) and the
QuantiTech SYBR Green PCR kit (Qiagen) according to
manufacturer’s protocol. Specific primers for each gene assayed
were purchased from Sigma and sequences were as follows; 14-3-
3f; (Fw59-ACCGTTACTTGGCCGAGGTT-3, Rv59-
GCAGGCTTTCTCTGGGGAGT-39), 14-3-3c; (Fw59- CAG-
CAGCATCGAGCAGAAGA-39, Rv59-
CTGGGTCTCGCTGCAGTTCT-39), 14-3-3e (Fw59- GGGAG-
TACCGGCAAATGGTT-39, Rv59-
TCTGCTGCCTCCTTCCTGTC-39), Grp78 (Fw59 TGCAG-
CAGGACATCAAGTTC-39, Rv59-CTGCATGGGT-
GACCTTCTTT-39), Xbp1s (Fw59- GAGTCCGCAG-
CAGGTG-39, Rv59-AAGGGAGGCTGGTAAGGAA-39), b-
actin (Fw59- AGGTGTGATGGTGGGAATGG-39, Rv59-
GGTTGGCCTTAGGGTTCAGG-39). The data were normal-
ised to b-actin and relative mRNA transcript levels were quantified
using the standard DDCT method.
Subcellular Fractionation
Hippocampi were fractionated to obtain the cytoplasm,
mitochondria, nuclear and microsome-enriched fractions, ac-
cording to previous methods [15]. Briefly, samples were
homogenized in a mannitol/sucrose buffer containing a protease
inhibitor cocktail and then centrifuged twice at 12006g for
10 min. The post-nuclear supernatant was then centrifuged
twice at 10 0006g for 15 min and the resulting mitochondrial
pellet was resuspended in a sucrose buffer and purified through
a percoll bilayer by centrifugation at 41 0006g for 30 min. The
crude cytosolic fraction was then centrifuged at 100 0006g for
1 h to separate the microsomal and cytosolic fractions.
Following fractionation, protein samples (20 mg) were boiled in
gel-loading buffer and then separated by 12% SDS-PAGE.
Proteins were transferred to nitrocellulose membranes and then
incubated with appropriate antibodies. Membranes were then
14-3-3f Protects against ER Stress and Seizures
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incubated with appropriate secondary antibodies (1:2000 dilu-
tion) followed by chemiluminescence detection on a FujiFilm
Las4000 imager.
Histopathology and Immunohistochemistry
Fresh-frozen brains were processed on a cryostat in the coronal
plane and 12 mm sections collected at the level of dorsal and
ventral hippocampus [31]. Sections were nissl-stained using
standard techniques [36]. DNA fragmentation was analyzed using
terminal deoxynucleotidyl dUTP nick end labeling (TUNEL)
(DeadEnd Fluorometric TUNEL system, Promega) as described
[34]. Irreversible neuronal injury was assessed using Fluoro-Jade B
(FJB) staining [34]. Briefly, sections were post-fixed, incubated in
0.006% potassium permanganate, rinsed and transferred to
0.001% FJB solution (Chemicon Europe Ltd., Chandlers Ford,
UK). Sections were then rinsed, dried, cleared and mounted in
DPX (Sigma–Aldrich). For immunohistochemistry, sections were
post-fixed, permeabilized, blocked in 5% goat serum and
incubated overnight with antibodies against; NeuN (1:400) and
KDEL (1:500) (Millipore). Sections were washed and incubated
with secondary antibodies conjugated with AlexaFluor 488 for
NeuN or AlexaFluor 568 for KDEL (Biosciences Ltd). Sections
were mounted with medium containing DAPI (Vector Laborato-
ries Ltd) and examined using a Hamamatsu Orca 285 camera
attached to a Nikon 2000s epifluorescent microscope. Counts were
performed under 206magnification lens with a counting window
area of 725 mm6550 mm and were the average of those from two
adjacent sections.
For 14-3-3 immunohistochemistry, free floating coronal
sections were stored in a 24 well plate in an anti-freeze solution
containing ethylene glycol. Sections were treated with 1% H2O2
to deactivate peroxidises and then blocked with 10% BSA/FBS
solution for 90 min. The following antibodies were then applied
to sections overnight at 4˚C; 14-3-3 f, c (1:1,000, Santa Cruz
Biotechnology), ZnT3 (1:100, Synaptic Systems). Sections were
then incubated with biotinylated antibodies with horse/donkey
serum for 90 min before being treated with Avidin ABC
peroxidise complex for 1 h. Sections were washed then
incubated with DAB, washed again, mounted and coverslipped.
For immunofluorescence microscopy, free-floating sections were
stained with anti-myc and then either NeuN or GFAP followed
by either AlexaFluor 488 or AlexaFluor 568–conjugated
secondary antibodies.
Data Analysis
All data are presented as mean 6 standard error of the mean.
Gel densitometry was undertaken using gel-scanning integrated
optical density software (AlphaEaseFC v4.0). Two group compar-
isons were made using Student’s t test (GraphPad Instat).
Significance was accepted at p,0.05.
Results
Distribution of myc-14-3-3f Transgene in the Mouse
Brain
Heterozygous transgenic mice overexpressing myc-tagged
mouse 14-3-3f under the EF-1a promoter on a SJL background
were bred and genotyped as before [30]. Mice were born at
expected rates and developed normally. EF-1a is constitutively
expressed in the brain and we began by characterizing the
distribution of the 14-3-3f transgene in different brain regions,
by western blot detection of the myc tag (Figure 1A). Myc-14-3-
3f was present in all major subfields of the mouse hippocampus,
at its expected molecular weight of 34 kD (representing the
28 kD 14-3-3f protein plus the 6 kD myc tag). Myc-14-3-3f was
also detectable in the neocortex, cerebellum, striatum and brain
stem (Figure 1A). To support these data we stained tissue
sections from wild-type and 14-3-3ftg mice using antibodies
against 14-3-3f (Figure 1B). Endogenous 14-3-3f was detected
mainly in neurons in the CA pyramidal layers and in granule
neurons in the dentate gyrus, in a somal distribution (Figure 1B).
Higher immunoreactivity for 14-3-3f was evident in all
hippocampal subfields in 14-3-3ftg mice (Figure 1B). We did
not detect significant 14-3-3f immunoreactivity in glia. Immu-
noreactivity for 14-3-3c was not different between genotypes
(Figure 1B, far right panels). Double immunofluorescence
staining of hippocampal sections for myc and either NeuN or
glial fibrillary acidic protein (GFAP) confirmed the transgene
was primarily expressed in neurons (Figure 1C).
We next examined subcellular fractions from the hippocampus
of wild-type and 14-3-3ftg mice to determine if the myc-14-3-3f
distributed normally within cells. Immunoblotting using specific
markers confirmed purified nuclear, mitochondrial, cytosolic and
ER-containing microsome fractions (Figure 1D). The b, e and g
isoforms were present exclusively in the cytosolic fraction of the
mouse hippocampus (Figure 1E). In contrast, 14-3-3f and 14-3-3c
were found in all cellular compartments (Figure 1E). The myc-
tagged 14-3-3f was also present in each subcellular fraction
(Figure 1E).
14-3-3f Over-expression does not Produce
Compensatory Changes in Other 14-3-3 Isoforms
We next investigated whether over-expression of 14-3-3f led to
compensatory changes to levels of other 14-3-3 isoforms. Western
blot analysis of microdissected hippocampus revealed normal
levels of various 14-3-3 isoforms, including 14-3-3b, 14-3-3e, 14-3-
3c and 14-3-3g, in 14-3-3ftg mice (Figure 1F), indicating that
overexpression of 14-3-3f does not produce changes to other 14-3-
3 isoforms in the hippocampus. Real-time PCR analysis confirmed
,two-fold higher 14-3-3f transcript levels in transgenic mice in all
hippocampal subfields whereas there were no mRNA differences
in expression of other 14-3-3 isoforms in the hippocampus of 14-3-
3ftg mice (Figure 1G and data not shown).
Normal Hippocampal Morphology in 14-3-3ftg Mice
We next examined hippocampal morphology in 14-3-3ftg mice.
Nissl-stained sections of 14-3-3ftg mice were indistinguishable
from wild-type mice (Figure 2A). Staining for the zinc transporter
protein ZnT3 confirmed 14-3-3ftg mice have a normal distribu-
tion of mossy fibers (Figure 2B). Mouse body weight was normal
although brain weight was slightly lower (Figure 2C, D).
Immunostaining and western blotting for the mature neuron
marker NeuN determined hippocampal neuron distribution and
counts were normal in the 14-3-3ftg mice (Figure 2E, F). No
differences were observed for levels of the astrocyte marker GFAP
or the microglia marker Iba1 (Figure 2G, H).
Normal Expression of Apoptosis-associated Proteins in
14-3-3ftg Mouse Hippocampus
14-3-3 proteins oppose apoptosis by sequestering pro-apoptotic
proteins including Bad, the transcription factor Foxo3 and ASK-1
[2], and recent work suggests 14-3-3 may also regulate autophagy
[37,38]. Western blot analysis of microdissected hippocampal
subfields from 14-3-3ftg mice found no differences from wild-type
for levels of Bad, Foxo3, Bax or Bim (Figure 2I and data not
shown), or any differences in autophagy-related proteins LC3II or
Atg5/12 [38] (Figure 2J).
14-3-3f Protects against ER Stress and Seizures
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Reduction in ER Chaperones and UPR Proteins in 14-3-
3ftg Mice
RNAi-mediated down-regulation of 14-3-3f in organotypic
hippocampal cultures results in an ER stress-like response that
features increased levels of ER chaperones, including Lys-Asp-
Glu-Leu (KDEL)-containing proteins such as Grp78 and Grp94
[17]. To investigate whether overexpression of 14-3-3f alters
ER chaperones or the UPR in vivo we began by staining tissue
sections from wild-type and 14-3-3ftg mice with antibodies
against KDEL (Figure 3A). KDEL immunoreactivity was
detected in all CA neuronal populations and in the granule
neurons of the dentate gyrus in wild-type mice. Lower KDEL
immunoreactivity was apparent in hippocampal sections from
14-3-3ftg (Figure 3A). This difference was confirmed using
western blot analysis of lysates from CA1, CA3 and the dentate
gyrus-enriched portions of the hippocampus (Figure 3B-D).
Basal mRNA levels of Grp78 and Grp94 were not different
between wild-type and 14-3-3ftg mice (Figure 3E and data not
shown).
No differences were found between wild-type and 14-3-3ftg
mice for CA3, CA1 or dentate gyrus levels of calnexin or eIF2a
(Figure 3F). In contrast, levels of phospho-eIF2a, ATF4 and
ATF6 were lower in the CA3 subfield of 14-3-3ftg mice
(Figure 3F, G), although levels of phospho-eIF2a and ATF4 and
ATF6 were not consistently different from wild-type in the
dentate gyrus or CA1 subfield (Figure 3F, G and data not
shown). Levels of the spliced transcript of Xbp1 were not
detectable in 14-3-3ftg mice whereas low levels of this were
detected in wild-type animals, which were increased in mice
subject to seizures (Figure 3H).
Figure 1. Distribution of the myc-tagged 14-3-3f transgene in mouse brain. (A) Western blot analysis (n=1 per lane) of microdissected
brain regions from wild-type (wt) and 14-3-3ftg mice immunoblotted with antibodies against the myc tag confirm expression of the transgene in CA
subfields, dentate gyrus (DG), cortex (Cx), cerebellum (Cb), striatum (Str) and brain stem (BS). (B) 14-3-3f immunostaining in hippocampal tissue
sections showing higher immunoreactivity (IR) in 14-3-3ftg compared to wt mice. Panels to the far right show sections stained for 14-3-3c revealing
normal neuronal distribution and level between wt and 14-3-3ftg mice. (C) Representative fluorescence immunostaining of the CA1 subfield showing
(top) myc (red) with NeuN (green) co-localization and (bottom) myc (green) with GFAP (red) confirming mainly neuronal expression of the transgene.
(D) Immunoblots of SJL mouse hippocampal fractions (n= 1 per lane) for the select presence of markers of the nucleus (Nuc), mitochondria (Mito),
cytoplasm (Cyto) and microsome-containing ER fraction (Micro). (E) Western blots from pools of 14-3-3ftg mouse hippocampi (n=1 per lane) show
the presence of various isoforms in different compartments. Note, endogenous 14-3-3f and myc-14-3-3f are similarly distributed in each fraction. (F)
Protein levels of various 14-3-3 isoforms in wt and 14-3-3ftg mice hippocampal subfields (n= 1 per lane). (G) Real-time PCR measurement of f, c and e
14-3-3 isoform levels in wt and 14-3-3ftg mice (n=3 per group). *p,0.05 compared to wt. Scale bars in B, C, 160 mm.
doi:10.1371/journal.pone.0054491.g001
14-3-3f Protects against ER Stress and Seizures
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Figure 2. Hippocampal morphology and levels of apoptosis-
and autophagy-related proteins in 14-3-3ftg mice. (A) Nissl-
stained sections of wt and 14-3-3ftg mice. Scale bar, (top) 600 mm;
(bottom), 330 mm. (B) Immunohistochemistry showing similar pattern of
ZnT3 staining, a protein present in mossy fibers, in wt and 14-3-3ftg
mice. Scale bar, 500 mm. (C) Body weight in wt and 14-3-3ftg mice at 6
weeks of age (n=8 per group). (D) Brain weight in wt and 14-3-3ftg
mice at 6 weeks of age (n=6 per group). *p,0.05 compared to wt. (E)
NeuN counts in hippocampal subfields from sections of dorsal
hippocampus from wt and 14-3-3ftg mice (n=6 per group). (F-J)
Representative western blots (n= 1 per lane) showing similar levels of
(F) NeuN, (G) the astrocyte marker GFAP, (H) microglia marker Iba1, (I)
apoptosis-associated 14-3-3 binding proteins and (J) autophagy-related
14-3-3 binding proteins, in adult wt and 14-3-3ftg mice.
doi:10.1371/journal.pone.0054491.g002
Figure 3. Reduced levels of ER and UPR-related proteins in 14-
3-3ftg mice. (A) Representative KDEL (green) immunostaining for wt
and 14-3-3ftg mice hippocampus. Neurons are identified by NeuN
counterstaining (red). Merged panels confirm staining is neuronal. Note,
lower KDEL immunoreactivity in 14-3-3ftg mice. Scale bar (top),
700 mm; (bottom), 150 mm. (B) Representative western blots (n= 1 per
lane) showing KDEL-containing proteins in microdissected subfields of
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14-3-3f Overexpression Protects Against ER Stress-
induced Neuronal Death in vivo
In view of the lower levels of ER stress/UPR-related proteins,
we postulated that 14-3-3ftg mice may show altered vulnerability
to ER stress in vivo. To test this idea, wild-type and 14-3-3ftg mice
were given an intracerebroventricular injection of the ER stressor
tunicamycin. In wild-type mice this resulted in extensive death of
dentate granule neurons 48 h later, as detected by Fluor-Jade B
(FJB) staining (Figure 4A) and TUNEL staining (Figure 4C). In
contrast, tunicamycin-induced neuronal death was significantly
reduced in 14-3-3ftg mice (Figure 4B, D). This was despite lower
levels of many ER/UPR-related proteins including Grp94,
phospho-eIF2a and phospho-Ire1 and lower levels of caspase-12
(Figure 4E, F). ATF4 and ATF6 levels were not different after
tunicamycin (Figure 4E).
Seizure Severity is not Altered by 14-3-3f Overexpression
in Mice
Reduced 14-3-3f levels have been shown to increase vulnera-
bility to kainic acid in organotypic hippocampal slice cultures [17].
To determine whether over-expression of 14-3-3f has effects on
seizure-induced neuronal death in vivo we examined the response
of mice to status epilepticus. Intra-amygdala microinjection of
kainic acid produces prolonged seizures which spread to the
hippocampus via the entorhinal cortex and perforant pathway.
Mossy fibres from dentate granule neurons synapse directly on
CA3 pyramidal neurons, which are particular vulnerable to
seizure-induced neuronal death in this model [31]. Protein levels
of kainic acid receptors appeared normal in 14-3-3ftg (Figure 5A).
Forty minute EEG recordings from skull-mounted electrodes
detected no differences in baseline total power or frequency
parameters in 14-3-3ftg mice (Figure 5B, C). Next, we recorded
seizures in wild-type and 14-3-3ftg mice. Seizure durations in
wild-type mice were similar to those reported previously for SJL
mice in this model [31]. Electrographic seizure EEG was not
different in 14-3-3ftg mice (Figure 5D, E).
14-3-3f Overexpression Protects Against Seizure-induced
Neuronal Death in vivo
Hippocampal damage in SJL mice subjected to intra-amygdala
kainic acid-induced status epilepticus is found extensively in the
CA3 subfield, with additional neuronal death in the CA1 subfield
and hilus [31]. We next examined seizure-damage 72 h after
status epilepticus in wild-type and 14-3-3ftg mice. As expected,
FJB staining of tissue sections from wild-type mice revealed
hippocampal damage was most extensive in the ipsilateral CA3
subfield (Figure 6A). Seizure damage was also present in the CA1
subfield and hilus (Figure 6A). FJB-staining was reduced in 14-3-
3ftg mice in all subfields (Figure 6A, B). Supporting these results,
staining for irreversible DNA fragmentation using TUNEL
confirmed extensive neuronal death in the CA3, CA1 and hilus
of wild-type mice, which was reduced in 14-3-3ftg mice (Figure 6A,
B). 14-3-3ftg mice also displayed higher levels of normal NeuN
staining in each hippocampal subfield (Figure 6B and data not
shown). Western blot analysis of protein lysates from wt and 14-3-
3ftg mice revealed significantly lower levels of several proteins
related to ER stress and the UPR in the CA3 subfield, including
Grp 78 and 94, phospho-eIF2a and caspase-12 (p,0.05; n=3 per
group, data not shown).
Finally, to support the in vivo seizure data we exposed primary
cultures of hippocampal neurons to kainic acid, an in vitro model of
excitotoxicity [34]. Kainic acid treatment produced ,70% cell
death in primary hippocampal cultures from wild-type SJL mice.
In contrast, cell death was significantly lower in primary
hippocampal cultures from 14-3-3ftg mice (Figure 6C).
Discussion
In the present study we report that transgenic overexpression of
14-3-3f in mice alters basal levels of proteins involved in the UPR
pathway. 14-3-3f overexpression nevertheless potently protected
the hippocampus against ER stress and status epilepticus in vivo.
These results suggest that restitution or delivery of 14-3-3f may
protect against neurologic or neurodegenerative injuries in which
excitotoxicity, ER stress or an impaired UPR response is a causal
patho-mechanism.
14-3-3 proteins are increasingly recognized as crucial molecular
chaperones during brain development, in neuronal function and
disease [2]. There is some functional redundancy among certain
14-3-3 isoforms [39], although loss of 14-3-3f does not appear to
be compensated by increased levels of other isoforms [5,6].
Likewise, 14-3-3 isoforms display selectivity in their capacity to
prevent neuronal death according to the nature of the stressor,
which may derive from their interacting partners and subcellular
distribution [40]. The present study is the first to characterize the
brain phenotype of mice overexpressing 14-3-3f. The animals
were originally developed to explore tumor-promoting effects of
14-3-3f overexpression [30] and the mice do develop tumors but
beyond the time when mice were used presently (E. J-M.,
unpublished data). The overexpressed 14-3-3f was found
throughout the mouse hippocampus and detectable in the cytosol,
nucleus, mitochondria and ER-containing fractions. Thus, the
transgene expressed and distributed similarly to the endogenous
protein. This excludes features of the phenotype of the mice being
due to erroneous distribution of extra 14-3-3f to cell populations
or compartments in which the protein is not ordinarily present. 14-
3-3f protein was recently reported to be restricted to the CA
pyramidal neurons and granule neurons of the hippocampus in
adult mice [6,15,17]. Our studies confirmed these cells were
immunoreactive for 14-3-3f, and expressed the myc-tagged
transgene, but we detected the transgene in other brain regions,
consistent with other studies showing 14-3-3f to be present outside
the hippocampus in adult brain [41].
14-3-3f has been reported to regulate neurite outgrowth and is
required for normal hippocampal development [6,42]. Indeed,
deletion of 14-3-3f results in mis-located pyramidal neurons and
changes to the mossy fiber pathway within the infra- and supra-
pyramidal layer and a predicted increased excitatory drive onto
CA3 pyramidal neurons [6]. We did not detect any hippocampal
abnormalities in 14-3-3ftg mice, indicating that overexpression of
14-3-3f does not produce an opposite phenotype to gene deletion.
We also detected no differences in body weight, reported for 14-3-
3f2/2 mice [6] although a smaller brain weight was noted. The
cause of this is uncertain and differences in neuron or glia
populations were not observed. Indeed, consistent with normal
brain development, we found no differences in baseline or seizure
wt and 14-3-3ftg mice. (C, D) Basal Grp78 and Grp94 protein levels in wt
and 14-3-3ftg mice (n=3 per group). (E) Real-time PCR measurement of
Grp78 levels in wt and 14-3-3ftg mice in each subfield (n=3 per group).
(F) Western blots (n=1 per lane) showing levels of various ER-related
proteins in the CA3 subfield of 14-3-3ftg mice compared to wt mice. (G)
Graphs showing lower basal levels of p-eIF2a, ATF6 and ATF4 in select
hippocampal subfields (n=3 per group). (H) Gel showing levels of the
spiced form of Xbp1 from hippocampal lysates of; (lane 2) WT mice
subject to seizures levels, (lane 3) Wt mice, (lane 4) 14-3-3ftg mice. Lane
1 is a ladder. *p,0.05 compared to wt.
doi:10.1371/journal.pone.0054491.g003
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EEG in 14-3-3f transgenic mice, establishing an equivalent
episode of status epilepticus was likely incurred and thus
differences in damage can be confidently assigned to altered cell
death/survival signalling rather than due to reduced seizures.
14-3-3 proteins regulate apoptosis by sequestering pro-apoptotic
proteins including Bad and ASK-1, which are activated by
excitotoxic insults to the brain and contribute to neuronal death in
models of seizure and stroke [12,43]. Overexpression of 14-3-3f
did not alter resting levels of apoptosis-associated proteins to which
it is known to bind, or change levels of autophagy-related proteins.
Kainic acid receptors, which are trafficked from the ER by a 14-3-
3-regulated mechanism [4], were also at normal levels in 14-3-3ftg
mice. Nevertheless, additional 14-3-3f may function as a pool to
buffer against pro-apoptotic proteins released from endogenous
14-3-3f or other isoforms during apoptosis. The main molecular
adjustment in 14-3-3ftg mice, however, was downregulation of
Figure 4. 14-3-3ftg mice are protected against ER stress-induced neuronal death in vivo. (A) Representative FJB staining of wt and 14-3-
3ftg mouse hippocampus 48 h after i.c.v. injection of tunicamycin (1 ml, 50 mM). Scale bar, 150 mm. Dotted lines depict upper and lower blades of the
granule cell layer. str. gr., stratum granulosum. (B) Counts of FJB-positive cells 48 h after tunicamycin in wt and 14-3-3ftg mice (n= 5 per group;
**p,0.01 compared to wt). (C, D) Representative photomicrographs showing TUNEL staining in wt and 14-3-3ftg mice 48 h after tunicamycin
injection and graph quantifying the difference (n= 5 per group; ***p,0.001 compared to wt. (E, F) Representative western blots (n= 1 per lane) and
semi-quantification of UPR and ER-associated protein levels between wt and 14-3-3ftg mice (n= 3 per group; *p,0.05 compared to wt).
doi:10.1371/journal.pone.0054491.g004
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proteins involved in the UPR pathway. Most prominent was
reduced levels of KDEL-containing proteins although all branches
of the UPR were affected. This was probably due to post-
translational mechanisms since transcript levels of several tested
genes were normal. 14-3-3f overexpression did have effects on
mRNA, however, reducing Xbp1 splicing, a consequence of the
activation of the IRE1 branch of the UPR that promotes increased
expression of ER chaperones [22]. Taken together, these data
suggest overexpressed 14-3-3f may produce a selective adjustment
of the UPR. Since this included reduced levels of proteins involved
in folding, this is consistent with 14-3-3f functioning as a sweeper
of mis-folded proteins [3].
ER stress is implicated as a patho-mechanism underlying
neurodegeneration in several diseases, including epilepsy [44],
although NMDA receptor-induced neuronal death can occur
independently of ER stress in vivo [45]. Studies here demonstrated
that overexpressed 14-3-3fwas capable of protecting against ER
stress induced by tunicamycin. Tunicamycin causes ER stress by
preventing N-glycosylation of proteins, thus resulting in a build-up
of proteins in the ER and triggering the UPR and ER stress-
induced apoptosis, although direct effects on neurotransmission
have been reported [46]. Tunicamycin injection into the brain
caused the selective death of neurons within the dentate gyrus,
consistent with in vitro reports [17]. 14-3-3f strongly protected
Figure 5. Baseline and seizure EEG in 14-3-3ftg mice. (A). Protein levels of the kainic acid receptors GluR6/7 and KA2 in microdissected
subfields of hippocampus from wt and 14-3-3ftg mice. (B) Analysis of baseline EEG parameters during 40 min recordings from skull of wt and 14-3-
3ftg mice. No differences were detected between genotypes (n= 6 per group). (C) Representative EEG spectral activity plot of baseline EEG in wt and
14-3-3ftg mice. (D, E) Representative spectral activity plot of EEG frequency and amplitude, and quantitative analysis of seizure duration (high
amplitude and high frequency discharges) for wt and 14-3-3ftg mice during the 40 min after intra-amygdala microinjection of kainic acid. No
differences were detected between genotypes (n=6-7 per group).
doi:10.1371/journal.pone.0054491.g005
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Figure 6. 14-3-3ftg mice are protected against seizure-induced neuronal death in vivo and in vitro. (A) Representative FJB and TUNEL
staining for wt and 14-3-3ftg mice 72 h after status epilepticus for the CA1, CA3 and hilar regions. Scale bar, 120 mm. (B) Semi-quantification of
seizure damage and neuron survival (NeuN counts) for wt and 14-3-3ftg mice (n=6-10 per group). (C) Primary cultures of hippocampal neurons from
wt and 14-3-3ftg mice were treated with kainic acid and then cell death determined as percentage propidium iodide (PI) positive. (Panels above)
Representative photomicrographs of PI-stained neurons 24 h after KA treatment. Scale bar, 25 mm. Graph shows reduced cell death in 14-3-3ftg mice
(n=3 per group). *p,0.05; **p,0.01; ***p,0.001 compared to wt.
doi:10.1371/journal.pone.0054491.g006
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against tunicamycin-induced neuronal death despite the lower
resting levels of UPR/ER stress proteins. Even after treatment,
levels of many UPR/ER stress proteins remained lower in 14-3-
3ftg mice, excluding an effect secondary to normalization of levels.
Higher 14-3-3f levels may therefore reduce the stress caused by
tunicamycin and over-expressed 14-3-3f may be sufficient to
protect in the absence of a complete complement of ER stress
chaperones. 14-3-3f delivery may be a means to reduce ER stress
where the normal UPR response is inadequate or otherwise
disrupted, such as in certain neurologic and neurodegenerative
diseases [47]. The data also compliment the findings of 14-3-3f
silencing in hippocampus, which triggers up-regulation of KDEL-
containing proteins and sensitizes against tunicamycin-induced cell
death [48].
A major finding in the present study was that overexpression of
14-3-3f potently protected against seizure-induced neuronal death
in vivo. Protection was found for both pyramidal and hilar
interneurons, indicating 14-3-3f overexpression protects regardless
of neuronal phenotype or location within the hippocampal
circuitry. These results compliment earlier work that showed
lowering 14-3-3f levels in the mouse hippocampus increased
neuronal death after kainate treatment of organotypic cultures
[48]. The extent of protection is similar and in several cases
greater than achieved by deletion of pro-apoptotic members of the
Bcl-2 family in the same model [49,50,51]. This would be
consistent with 14-3-3f function either upstream or being involved
in curtailing cell death via actions in more than one compartment.
Over-producing an anti-apoptotic protein may also be more
effective than deleting a pro-apoptotic protein. Again, the
protection obtained was in spite of a lower compliment of ER
stress chaperones in these mice. This agrees with in vivo evidence
that NMDA-dependent neuronal death in vivo is not ER stress-
dependent [45]. This could mean that either 14-3-3f is more
effective than these proteins at protection in this model, or that the
protection derives from functions in addition to ER stress-related
cell death. This is likely; we detected 14-3-3f overexpression
throughout the cell and 14-3-3 is able to sequester various pro-
apoptotic Bcl-2 family proteins which contribute to seizure-
induced neuronal death in the model [12,52]. Whether or not the
reduced hippocampal damage in 14-3-3ftc mice would result in a
beneficial effect on the post-status epilepticus epilepsy phenotype is
uncertain, although our previous studies in which hippocampal
damage was reduced by genetic or other means, led to fewer
spontaneous recurrent seizures [51,53].
Levels of several proteins associated with the UPR have been
found to be higher in the hippocampus of patients with temporal
lobe epilepsy [26,27]. Levels of these proteins were generally
lower, however, in the hippocampus of 14-3-3f transgenic mice
suggesting the model does not phenocopy this molecular feature of
human temporal lobe epilepsy. Nevertheless, elevated 14-3-3f
levels were reported in the microsome-containing fraction of
hippocampus from patients with temporal lobe epilepsy [15].
Although we cannot directly compare the higher 14-3-3f levels in
the transgenic mice with those in patient brain, we may speculate,
on the basis of our results here, that increased 14-3-3f in
intractable human epilepsy could be protective against ongoing
neuron loss. We note, however, that 14-3-3f is not uniformly
neuroprotective, and fails to prevent neurodegeneration in models
of Parkinson’s disease [40]. 14-3-3f can also promote phosphor-
ylation of Tau and chronic over-expression might have potentially
deleterious effects on the brain [54,55], which could be assessed
using the present model. Any strategy to enhance 14-3-3f
expression may provide neuroprotection only against the acute
effects of prolonged seizures or perhaps stroke, which share
common patho-mechanisms such as excitotoxicity and apoptosis-
associated signalling [11].
In summary, the present study demonstrates that 14-3-3f
overexpression results in a selective downregulation of UPR
pathways and confers protection against ER stress- and seizure-
induced neuronal death in the mouse hippocampus. Restitution or
overexpression of this 14-3-3 isoform may be a potential
therapeutic approach for status epilepticus but not necessarily all
CNS diseases associated with impaired 14-3-3f expression [2].
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